Tangen Biosciences, Inc. — Form D

Tangen Biosciences, Inc. of BRANFORD, CT, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-01. The offering totals $20.0M, of which $11.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Christopher BenoitDirectorLowell, MA
Richard Birkmeyer, PhDDirectorBranford, CT
John DavidsonDirectorGreenwood Village, CO
Christopher McLeodDirectorBranford, CT
Dan WagnerDirectorWashington, DC
Richard Birkmeyer, PhDExecutive OfficerBranford, CT
Brian ChiricoExecutive OfficerBranford, CT
John DavidsonExecutive OfficerGreenwood Village, CO
Daniel V WagnerDirectorWoodbridge, CT
Alan V LevinDirectorBranford, CT
Richard C Birkmeyer, PhDDirectorBranford, CT
Richard C Birkmeyer, PhDExecutive OfficerBranford, CT
Vance V KershnerDirectorBranford, CT
Christopher V McLeodDirectorBranford, CT
John V DavidsonDirectorBranford, CT
John V DavidsonExecutive OfficerBranford, CT
John NobileDirectorBranford, CT
John Richard NobileDirectorBranford, CT
John Richard NobileExecutive OfficerBranford, CT
John Richard NobilePromoterBranford, CT
John Richard DavidsonDirectorBranford, CT
John Richard DavidsonExecutive OfficerBranford, CT
John Richard DavidsonPromoterBranford, CT

Other filings by this issuer (4)

FiledFormOfferingSold
2023-06-06D$2.5M$465K
2019-03-22D$11.1M$6.7M
2016-11-02D$8.0M
2015-12-28D$3.0M$2.0M

More